What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Signal Peptides: Function, Types, and Mechanisms in Protein Targeting

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Introduction to Signal Peptides

Every protein synthesized in a cell begins its life at the ribosome, but not every protein remains where it is made. A substantial fraction of the proteome must travel to specific subcellular compartments—the endoplasmic reticulum (ER), mitochondria, chloroplasts, peroxisomes, or the nucleus—or be secreted entirely from the cell. This trafficking is governed by short, often N-terminal amino acid sequences that act as molecular zip codes. These sequences are called signal peptides (also known as signal sequences or targeting signals).

A signal peptide is a short (typically 15–30 amino acid residues) stretch of amino acids that directs a newly synthesized protein to a specific cellular destination. For secretory and membrane proteins, the signal peptide directs the ribosome–nascent chain complex to the ER membrane in eukaryotes or the plasma membrane in prokaryotes, where the protein is translocated across or inserted into the membrane. For organellar proteins, signal peptides direct import into mitochondria, chloroplasts, or peroxisomes. For nuclear proteins, a related but mechanistically distinct sequence—the nuclear localization signal (NLS)—mediates import through nuclear pore complexes.

Signal peptides are cis-acting elements: they are part of the protein they direct. They are typically located at the extreme N-terminus, though internal signal sequences exist (e.g., in some membrane proteins). They are recognized by dedicated protein machinery that couples translation to translocation, ensuring that proteins reach their correct destination with high fidelity.

What is a Signal Peptide?

A signal peptide is a linear sequence of amino acids, usually 15–30 residues long, that is present at the N-terminus of a nascent polypeptide. It is recognized co-translationally (during translation) by the signal recognition particle (SRP) in eukaryotes and bacteria, or post-translationally by other chaperone systems in mitochondria and chloroplasts. The signal peptide is often, but not always, cleaved off by a signal peptidase once the protein has been translocated across the membrane. The mature protein, now lacking the signal peptide, folds into its functional conformation in its destination compartment.

Signal peptides are not conserved in primary sequence—two signal peptides directing proteins to the same destination can share little or no sequence identity. Instead, they share physicochemical properties: a positively charged N-terminus, a hydrophobic core, and a polar C-terminal region. This degeneracy is functionally important: it allows a single recognition machinery (e.g., SRP) to recognize thousands of different signal peptides.

Historical Discovery

The concept of a signal peptide emerged from work in the early 1970s. Günter Blobel and David Sabatini proposed the "signal hypothesis" in 1971, suggesting that a short sequence at the N-terminus of secretory proteins directs the ribosome to the ER membrane. In 1975, Blobel and Bernhard Dobberstein provided experimental evidence using pancreatic microsomes: they showed that the mRNA for a secretory protein (immunoglobulin light chain) could be translated in vitro, and that the resulting protein was longer than the mature secreted form. When microsomal membranes were added during translation, the extra sequence was cleaved, producing the mature protein. This established that the extra sequence—the signal peptide—was both necessary and sufficient for ER targeting.

Blobel received the Nobel Prize in Physiology or Medicine in 1999 for this discovery, which laid the foundation for understanding protein trafficking. Subsequent work identified SRP, the translocon (Sec61 complex), and signal peptidase, completing the molecular picture of co-translational translocation. The principles established for the ER pathway were later found to apply, with variations, to mitochondrial and chloroplast protein import.

Structure and Common Features of Signal Peptides

Despite their sequence diversity, classical signal peptides share a tripartite structure. This architecture is conserved from bacteria to humans and is the basis for their recognition by targeting machinery.

N-Region, H-Region, and C-Region

A canonical signal peptide consists of three distinct regions:

N-Region (N-terminal region): 1–5 amino acids, typically positively charged. Lysine and arginine residues dominate. The positive charge interacts with the negatively charged phospholipid head groups of the target membrane and with the SRP or other recognition factors. In Gram-negative bacteria, the N-region also interacts with the SecA ATPase during post-translational translocation.

H-Region (hydrophobic core): 7–15 amino acids, composed predominantly of hydrophobic residues—leucine, isoleucine, valine, phenylalanine, and alanine. This region is the primary recognition motif for SRP. It adopts an α-helical conformation upon binding to the SRP54/M-domain, inserting into the SRP's hydrophobic groove. The length and hydrophobicity of the H-region determine the efficiency of SRP binding: longer and more hydrophobic cores bind more tightly. This is why signal peptides with a 10-residue leucine-rich core are among the strongest targeting signals.

C-Region (cleavage region): 3–7 amino acids, containing the signal peptidase cleavage site. This region is more polar than the H-region and often contains small, neutral amino acids at positions −1 and −3 relative to the cleavage site (the "−3, −1 rule"). Alanine, glycine, serine, and cysteine are preferred at these positions. The cleavage site itself is typically between position −1 and +1, where +1 is the first residue of the mature protein.

The tripartite structure is recognized by different components of the targeting machinery at different steps. The N-region is recognized by SRP's NG-domain and by the Sec translocon; the H-region is bound by SRP54; the C-region is recognized by signal peptidase.

Signal Peptide Length and Charge

Signal peptide length varies from 15 to 30 residues for most secretory proteins, but extremes exist. Some bacterial lipoproteins have signal peptides of 20–25 residues with a conserved "lipobox" motif (LXXC) at the cleavage site. Eukaryotic signal peptides tend to be slightly longer, averaging 22–25 residues. Mitochondrial targeting peptides are longer still—typically 20–60 residues—and are enriched in positively charged and hydroxylated amino acids (serine, threonine), with the ability to form an amphiphilic α-helix.

The net charge of the N-region is important. A net positive charge of +1 to +3 is typical. Mutations that remove this positive charge reduce translocation efficiency. Conversely, increasing the positive charge beyond +3 can slow translocation by causing the N-region to interact too strongly with negatively charged lipids or with the Sec61 channel. The H-region must be sufficiently hydrophobic (typically ≥ 8 consecutive hydrophobic residues) to engage SRP; a threshold hydrophobicity exists below which SRP binding fails and the protein is translated in the cytoplasm.

Mechanism of Signal Peptide Function

The journey of a signal peptide from the ribosome to the membrane involves a series of precisely orchestrated steps. The canonical pathway is the co-translational SRP-dependent pathway in eukaryotes, but variations exist for post-translational translocation and for organellar import.

SRP Recognition and Targeting

The process begins when the N-terminal signal peptide emerges from the ribosome exit tunnel. The tunnel is approximately 80–100 Å long and can accommodate about 30–40 amino acids. As soon as the signal peptide emerges, it is recognized by the signal recognition particle (SRP).

SRP is a ribonucleoprotein complex. In mammals, it consists of six protein subunits (SRP9, SRP14, SRP19, SRP54, SRP68, SRP72) and a 7S RNA molecule. The key subunit is SRP54, which contains three domains: an N-terminal domain (N), a GTPase domain (G), and a methionine-rich M-domain. The M-domain contains a hydrophobic groove that binds the H-region of the signal peptide. The NG-domain binds GTP and mediates interactions with the SRP receptor.

The steps are as follows:

Signal peptide emergence: The signal peptide emerges from the ribosome exit tunnel. SRP54's M-domain binds the H-region, while the N-region interacts with the positively charged surface of SRP54.
GTP loading: SRP54 binds GTP. This conformational change increases the affinity of SRP for the ribosome–nascent chain complex (RNC) and stabilizes the interaction.
Elongation arrest: SRP binding causes a transient pause in translation. This "elongation arrest" is mediated by SRP9/SRP14, which bind the 7S RNA and interact with the ribosome's elongation factor binding site. The arrest gives the RNC time to reach the ER membrane before the protein is fully synthesized.
Docking at the ER membrane: The SRP–RNC complex diffuses to the ER membrane, where it encounters the SRP receptor (SR), a heterodimer of SRα and SRβ. SRα is a peripheral membrane protein with a GTPase domain; SRβ is a transmembrane protein.
GTPase cycle and handoff: SRP54 and SRα exchange GTP, forming a stable SRP–SR complex. GTP hydrolysis in both proteins triggers a conformational change that releases the signal peptide from SRP54 and transfers it to the Sec61 translocon. SRP and SR dissociate, and SRP is recycled for another round of targeting.

The entire process—from signal peptide emergence to translocon engagement—takes approximately 1–2 seconds in vivo.

Translocation Across Membranes

The Sec61 translocon (in eukaryotes) or SecYEG complex (in bacteria) is a protein-conducting channel. It is a heterotrimeric complex: Sec61α (the pore-forming subunit), Sec61β, and Sec61γ. The channel is hourglass-shaped, with a narrow constriction (the "plug") that seals the pore in the closed state.

Upon signal peptide binding, the translocon undergoes conformational changes:

Signal peptide insertion: The signal peptide inserts into the lateral gate of Sec61, a site between transmembrane helices 2 and 7 of Sec61α. The H-region partitions into the lipid bilayer, while the N-region remains in the cytoplasm.
Plug displacement: The plug helix moves out of the pore, opening the channel to a diameter of approximately 15–25 Å—sufficient for an unfolded polypeptide chain to pass.
Ribosome docking: The ribosome binds to the cytosolic face of Sec61, forming a tight seal. The nascent chain is fed directly from the ribosome exit tunnel into the translocon pore.
Translation–translocation coupling: As the ribosome continues translation, the polypeptide is threaded through the pore in an N-to-C-terminal direction. For secretory proteins, the entire chain passes through. For membrane proteins, hydrophobic transmembrane segments exit through the lateral gate and partition into the lipid bilayer.

In bacteria, a parallel pathway exists for post-translational translocation. Here, the signal peptide is recognized by SecA, an ATPase that binds the SecYEG channel. SecA uses ATP hydrolysis to push the polypeptide through the channel in a stepwise manner, approximately 20–30 amino acids per ATP hydrolyzed. This pathway is used by proteins that are too large or too rapidly folded to be handled co-translationally.

Signal Peptide Cleavage

Once the protein has been translocated, the signal peptide must be removed to yield the mature protein. This is carried out by signal peptidase, a membrane-bound protease.

In eukaryotes, signal peptidase is a complex of five subunits (SPC18, SPC21, SPC22/23, SPC25, and SPC12) located in the ER lumen. The catalytic subunits are SPC18 and SPC21, which are serine proteases with an unusual active site: the catalytic serine is part of a Ser–His–Asp triad, but the enzyme is not inhibited by classical serine protease inhibitors, reflecting its unique mechanism.

Signal peptidase recognizes the C-region of the signal peptide, specifically the −3 and −1 positions relative to the cleavage site. Small, neutral residues (alanine, glycine, serine) are preferred. The enzyme cleaves the peptide bond between positions −1 and +1, releasing the signal peptide and the mature protein.

The cleaved signal peptide is rapidly degraded by signal peptide peptidase, an intramembrane aspartyl protease, and the resulting fragments are further degraded by cytosolic peptidases. This degradation is important: free signal peptides can be cytotoxic if they accumulate.

Not all signal peptides are cleaved. Some proteins retain their signal peptide as a membrane anchor (see "Cleavage vs. Non-Cleavage" below). In these cases, the signal peptide functions as a non-cleaved signal-anchor sequence, and the protein remains anchored to the membrane.

Types of Signal Peptides

Signal peptides are not a monolithic class. They vary in sequence, length, and mechanism depending on their target destination. The major categories are described below.

Secretory Signal Peptides

These are the classical signal peptides that direct proteins to the ER in eukaryotes or the periplasm/extracellular space in bacteria. They are recognized by SRP and cleaved by signal peptidase. Examples include the signal peptides of insulin, albumin, and immunoglobulins in humans, and of alkaline phosphatase (PhoA) and maltose-binding protein (MalE) in E. coli.

Secretory signal peptides are characterized by the tripartite N-H-C structure described above. They are typically 15–30 residues long, with a hydrophobic core of 7–15 residues. They direct proteins into the secretory pathway, from which they may be secreted from the cell or sorted to various compartments (lysosomes, endosomes, plasma membrane).

Mitochondrial and Chloroplast Targeting Peptides

Mitochondrial proteins synthesized in the cytosol are imported post-translationally. The targeting signal is an N-terminal presequence of 20–60 residues. Unlike ER signal peptides, mitochondrial presequences are not hydrophobic. Instead, they are enriched in positively charged residues (arginine, lysine) and hydroxylated residues (serine, threonine), and they have the potential to form an amphiphilic α-helix—a helix with one face positively charged and the other face hydrophobic.

The presequence is recognized by the translocase of the outer mitochondrial membrane (TOM complex), specifically by the receptor Tom20. The protein is then passed to the translocase of the inner membrane (TIM23 complex), which uses the membrane potential (Δψ) across the inner membrane to drive translocation. The presequence is cleaved by mitochondrial processing peptidase (MPP) in the matrix.

Chloroplast targeting peptides are similar but longer (30–100 residues) and are enriched in serine and threonine. They direct proteins to the chloroplast stroma via the TOC/TIC translocons. Unlike mitochondrial presequences, chloroplast transit peptides are not amphiphilic and do not require a membrane potential for import.

Nuclear Localization Signals

Nuclear localization signals (NLSs) are fundamentally different from other signal peptides. They are not cleaved, they are not hydrophobic, and they direct proteins through nuclear pore complexes rather than across a lipid bilayer.

The classical NLS consists of one or two stretches of basic amino acids. The monopartite NLS (e.g., SV40 large T antigen: PKKKRKV) is a single cluster of basic residues. The bipartite NLS (e.g., nucleoplasmin: KRPAATKKAGQAKKKK) consists of two basic clusters separated by a spacer of 10–12 residues.

NLSs are recognized by importin α, which binds the NLS and links the cargo to importin β. Importin β mediates translocation through the nuclear pore complex. Once in the nucleus, Ran-GTP binds importin β, triggering cargo release. The NLS remains part of the protein, which is why nuclear proteins stay in the nucleus after import.

Signal Peptide Examples in Model Organisms

Concrete examples illustrate the diversity and functional principles of signal peptides.

E. coli PhoA

Alkaline phosphatase (PhoA) in Escherichia coli is a periplasmic enzyme. Its signal peptide is 21 amino acids long:

MKQSTIALALLPLLFTPVTKA

The N-region (MKQST) has a net positive charge (+1). The H-region (IALALLPLLF) is hydrophobic. The C-region (TPVTKA) contains the cleavage site after the alanine at position 21. PhoA is translocated post-translationally via the SecB–SecA pathway. SecB, a chaperone, binds the mature region of PhoA and delivers it to SecA at the membrane. The signal peptide is cleaved by leader peptidase (LepB) in the periplasm.

PhoA is a classic experimental system: mutations in its signal peptide that reduce hydrophobicity of the H-region abolish translocation, and the protein accumulates in the cytoplasm in its precursor form.

Yeast α-Factor

The α-factor mating pheromone of Saccharomyces cerevisiae is synthesized as a precursor (prepro-α-factor) with a 19-residue signal peptide:

MRFPSIFTAVLFAASSALA

This signal peptide directs the precursor into the ER co-translationally via the SRP pathway. After cleavage by signal peptidase, the pro-α-factor undergoes glycosylation in the ER and Golgi, and the pro-region is cleaved by Kex2 protease in the Golgi to yield the mature 13-residue pheromone. Prepro-α-factor is a standard substrate for studying the yeast secretory pathway; its signal peptide is widely used in yeast expression vectors to secrete recombinant proteins.

Human Insulin

Preproinsulin is the primary translation product of the insulin gene. Its signal peptide is 24 residues long:

MALWMRLLPLLALLALWGPDAAA

The H-region (MRLLPLLALLALW) is highly hydrophobic. After translocation into the ER, the signal peptide is cleaved, yielding proinsulin. Proinsulin folds in the ER, forming three disulfide bonds, and is transported to the Golgi, where it is packaged into secretory granules. In the granules, proinsulin is cleaved by prohormone convertases PC1/3 and PC2 to yield mature insulin (A-chain and B-chain linked by disulfide bonds) and C-peptide.

Mutations in the insulin signal peptide cause diabetes. For example, a mutation that replaces a hydrophobic residue in the H-region with a polar residue impairs SRP binding, leading to cytosolic accumulation of preproinsulin and ER stress, ultimately causing β-cell death.

Methods to Study Signal Peptides

Understanding signal peptide function requires experimental approaches that can assess targeting, cleavage, and translocation efficiency.

Reporter Assays

The classic approach is to fuse a putative signal peptide to a reporter protein whose location can be easily assayed. Common reporters include:

Green fluorescent protein (GFP): Fluorescence microscopy reveals the subcellular location of the fusion protein. A signal peptide that directs ER targeting will produce a reticular/perinuclear pattern; a mitochondrial presequence will produce a punctate mitochondrial pattern.
**Alkaline phosphatase (PhoA) in E. coli:** PhoA is only active in the periplasm, where disulfide bonds can form. If a signal peptide directs PhoA to the periplasm, the cells produce blue colonies on X-phosphate plates. If the signal peptide is non-functional, PhoA remains in the cytoplasm, is not oxidized, and is inactive.
Invertase (SUC2) in yeast: Invertase is required for growth on sucrose. A signal peptide that directs invertase to the ER and then to the periplasm allows yeast to grow on sucrose plates. Non-functional signal peptides result in no growth.

Reporter assays are quantitative: the amount of reporter activity correlates with the efficiency of translocation.

Site-Directed Mutagenesis

Systematic mutagenesis of signal peptides has defined the sequence requirements for function. Key findings include:

Substituting hydrophobic residues in the H-region with charged residues (e.g., leucine → arginine) abolishes SRP binding and translocation.
Deleting the N-region positive charges reduces translocation efficiency by 50–80%.
Mutating the −1 and −3 positions of the C-region to large or charged residues prevents signal peptidase cleavage, leaving the protein anchored to the membrane as a precursor.

These experiments are typically performed by cloning the mutant signal peptide upstream of a reporter gene, transforming the construct into the appropriate host, and assaying reporter localization.

Computational Prediction (SignalP, Phobius)

Bioinformatics tools predict signal peptides from amino acid sequences. The most widely used is SignalP, which uses neural networks and hidden Markov models trained on experimentally verified signal peptides. SignalP predicts:

The presence of a signal peptide.
The cleavage site position.
The probability that the sequence is a signal peptide versus a transmembrane segment.

Phobius is a related tool that combines transmembrane topology prediction with signal peptide prediction, which is useful because signal peptides and transmembrane helices are both hydrophobic and can be confused.

Typical usage: input a protein sequence in FASTA format; the output includes a plot of signal peptide probability versus position, the predicted cleavage site, and a confidence score. A SignalP score above 0.5 (on a 0–1 scale) is generally considered positive, though thresholds vary by organism and tool version.

These tools are not infallible. They perform well on classical secretory signal peptides but are less accurate for non-classical signals, signal-anchor sequences, and organellar targeting peptides. Experimental validation is always required.

Clinical and Biotechnological Relevance

Signal peptides are not just academic curiosities; they are central to biotechnology and medicine.

Recombinant Protein Secretion

In the biopharmaceutical industry, signal peptides are used to direct recombinant proteins into the secretory pathway, where they can be harvested from the culture medium. This simplifies purification because the protein of interest is secreted rather than accumulated intracellularly.

Common expression systems and their signal peptides include:

***E. coli*:** The PelB signal peptide (from pectate lyase) directs proteins to the periplasm. The OmpA and MalE signal peptides are also used. However, E. coli is limited in its ability to secrete proteins to the culture medium; most proteins remain in the periplasm.
***Saccharomyces cerevisiae*:** The α-factor signal peptide (prepro region) is the standard for secretion. It directs proteins through the ER–Golgi pathway and into the medium. Human insulin (Humulin) was the first recombinant therapeutic produced this way.
***Pichia pastoris*:** The α-factor signal peptide is also used, and this yeast can secrete grams per liter of recombinant protein.
Mammalian cells (CHO cells): The human immunoglobulin signal peptide or the human serum albumin signal peptide directs secretion. Mammalian cells are required for complex proteins with post-translational modifications.

The choice of signal peptide can dramatically affect yield. A signal peptide that is poorly recognized by the host SRP will result in low secretion. Conversely, a signal peptide that is too hydrophobic can cause membrane accumulation. Optimization often involves testing multiple signal peptides for a given protein.

Signal Peptide Mutations and Disease

Mutations in signal peptides cause human disease by disrupting protein targeting. Examples include:

Preproinsulin signal peptide mutations: As noted, mutations in the H-region cause diabetes by impairing ER translocation and inducing ER stress.
Factor IX signal peptide mutations: A mutation in the factor IX signal peptide (Ala-10 → Thr) causes hemophilia B by reducing translocation efficiency, leading to reduced secretion of functional factor IX.
Surfactant protein C (SP-C): A mutation in the proprotein processing site causes interstitial lung disease by producing a misfolded protein that accumulates in alveolar type II cells.
Transthyretin: A signal peptide mutation (Ala-16 → Thr) causes amyloidosis by altering protein secretion and promoting amyloid fibril formation.

In each case, the mutation reduces the efficiency of targeting or cleavage, leading to protein mislocalization, aggregation, or degradation.

Common Pitfalls and Misconceptions

Students frequently make specific errors when learning about signal peptides. These are worth addressing directly.

Signal Peptide vs. Signal Patch

A signal peptide is a contiguous, linear sequence of amino acids at the N-terminus of a protein. It is part of the primary structure and is recognized as a linear motif.

A signal patch is a three-dimensional arrangement of amino acids that is formed by the folding of the protein. The residues that constitute the patch may be far apart in the primary sequence but come together in the folded structure. Signal patches are common in peroxisomal targeting (the PTS1 signal is a C-terminal tripeptide, but some proteins use internal patches) and in nuclear export signals.

The distinction matters: signal peptides can be predicted from sequence alone; signal patches cannot. Bioinformatics tools like SignalP only detect linear signals.

Cleavage vs. Non-Cleavage

Not all signal peptides are cleaved. There are two important exceptions:

Signal-anchor sequences: These are N-terminal sequences that function as both a signal peptide and a membrane anchor. They direct the protein to the ER but are not cleaved; instead, they remain in the membrane as a transmembrane segment. Type II membrane proteins (N-terminus in the cytoplasm, C-terminus in the lumen) have signal-anchor sequences. The uncleaved sequence serves as the membrane anchor.

Nuclear localization signals: NLSs are never cleaved. They are recognized by importins and direct the protein into the nucleus, but they remain part of the mature protein.

The presence of a signal peptide does not guarantee cleavage. The C-region must contain the appropriate cleavage site for signal peptidase. If the −1 and −3 positions are not small neutral residues, cleavage will not occur.

Predicting Signal Peptides

A common error is to assume that any hydrophobic N-terminal sequence is a signal peptide. This is not correct. Transmembrane helices are also hydrophobic and can be mistaken for signal peptides. The key differences:

Signal peptides are typically 15–30 residues; transmembrane helices are typically 20–25 residues but are followed by additional hydrophobic segments.
Signal peptides have a positively charged N-region and a cleavage site; transmembrane helices do not.
Signal peptides are usually at the very N-terminus; transmembrane helices can be anywhere in the protein.

Tools like Phobius are designed to distinguish these cases. A sequence predicted to be a signal peptide by SignalP but a transmembrane helix by Phobius should be treated with caution.

Another error is to assume that a protein without a signal peptide cannot be secreted. Some proteins are secreted via non-classical pathways (e.g., fibroblast growth factor 2, interleukin-1β) that do not use signal peptides or the ER–Golgi route. These proteins are secreted by direct translocation across the plasma membrane or by exocytosis of secretory lysosomes.

Frequently Asked Questions

What is a signal peptide?

A signal peptide is a short (15–30 amino acid) N-terminal sequence that directs a newly synthesized protein to a specific cellular destination, typically the ER in eukaryotes or the plasma membrane in prokaryotes. It is recognized by targeting machinery (e.g., SRP) and is often cleaved off after translocation.

How do signal peptides work?

A signal peptide emerges from the ribosome and is bound by SRP. SRP delivers the ribosome–nascent chain complex to the SRP receptor on the target membrane. The signal peptide is then inserted into the Sec61 translocon, which opens a channel through which the protein passes. After translocation, signal peptidase cleaves the signal peptide, releasing the mature protein.

What are the types of signal peptides?

The major types are: (1) secretory signal peptides (ER/periplasm targeting), (2) mitochondrial presequences, (3) chloroplast transit peptides, (4) nuclear localization signals, and (5) signal-anchor sequences. They differ in sequence, length, and mechanism of recognition.

Can you give an example of a signal peptide?

The E. coli PhoA signal peptide is MKQSTIALALLPLLFTPVTKA. It directs alkaline phosphatase to the periplasm. The human insulin signal peptide is MALWMRLLPLLALLALWGPDAAA, which directs preproinsulin into the ER.

What is the role of a signal peptide?

The role is to ensure that a protein reaches its correct subcellular destination. Without a signal peptide, a secretory protein would remain in the cytoplasm. The signal peptide is both necessary and sufficient for targeting: fusing it to a cytoplasmic protein redirects that protein to the secretory pathway.

Are signal peptides always cleaved?

No. Signal-anchor sequences are not cleaved and remain as membrane anchors. Nuclear localization signals are never cleaved. Cleavage depends on the presence of a recognition site for signal peptidase in the C-region.

How are signal peptides predicted?

Computational tools such as SignalP and Phobius predict signal peptides from amino acid sequences. SignalP uses neural networks to identify the signal peptide and cleavage site. Phobius combines signal peptide and transmembrane helix prediction. Experimental validation (e.g., reporter assays) is required to confirm predictions.

Key Takeaways

Signal peptides are short N-terminal sequences (15–30 residues) that direct proteins to the ER, mitochondria, chloroplasts, or nucleus.
They share a tripartite structure: a positively charged N-region, a hydrophobic H-region, and a polar C-region containing the cleavage site.
The canonical mechanism involves SRP recognition, targeting to the translocon, translocation through Sec61, and cleavage by signal peptidase.
Signal peptides are not conserved in sequence; they are recognized by physicochemical properties, not by specific amino acid motifs.
Mitochondrial and chloroplast targeting peptides are longer and more polar than ER signal peptides; nuclear localization signals are basic and never cleaved.
Signal peptides are essential for recombinant protein production and are mutated in several human diseases, including diabetes and hemophilia.
Bioinformatics tools (SignalP, Phobius) predict signal peptides but cannot replace experimental validation, especially for non-classical signals.